EDSA:NASDAQEdesa Biotech, Inc. Analysis

Edesa Biotech, Inc. is priced at $4.78, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 20.7%. Momentum indicators put RSI at 42.2 (neutral) with MACD reading bullish. The recent range runs from support at $4.12 up to resistance at $6.67.
The average analyst target implies 241.7% above today's level.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 88.9%, a beta of -0.68 and a maximum drawdown of 75.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.